Subscribe

Articles

Common Questions from NSCLC Patients and Their Caregivers
IWTI Best Practices in Lung Cancer Navigation
Common Questions from NSCLC Patients and Their Caregivers
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Interview with the Innovators
Videos
Addressing common questions from NSCLC patients and their caregivers Read More ›
Psychosocial Support for the NSCLC Patient
IWTI Best Practices in Lung Cancer Navigation
Psychosocial Support for the NSCLC Patient
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Interview with the Innovators
Videos
Providing psychosocial support and counseling for NSCLC patients and their family Read More ›
Educating NSCLC Patients on Adverse Event Management
IWTI Best Practices in Lung Cancer Navigation
Educating NSCLC Patients on Adverse Event Management
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Interview with the Innovators
Videos
Educating patients about cancer- and treatment-related side effect management Read More ›
Using the FDA Adverse Event Reporting System to Find Links Between Interstitial Lung Disease and CDK4/6 Inhibitors
Breast Cancer
Web Exclusives
Evaluation of real-world reports will help with the early clinical assessment of interstitial lung disease potentially associated with CDK4/6 inhibitors. Read More ›
Quality of Life in Breast Cancer Survivors Using an Electronic Home-Based Symptom Management and Mindfulness Training Program
Breast Cancer
Web Exclusives
An electronic home-based multidimensional cancer survivorship program did not clearly affect outcomes in women with breast cancer, although a positive impact was revealed in interviews. Read More ›
Impact of a CDK4/6 Inhibitor plus Fulvestrant on Overall Survival in Patients with Breast Cancer
Breast Cancer
Web Exclusives
Pooled analyses of overall survival shows the addition of CDK inhibitors to fulvestrant confers a consistent survival benefit in patients with breast cancer. Read More ›
Persistent Race-Associated Disparities in Genetic Testing of Patients with Breast Cancer
Breast Cancer
Web Exclusives
As mutation-associated targeted therapies are identified, it is critical to address genetic testing disparities. Read More ›
Differences in Toxicity Profiles and Impact on CDK4/6 Inhibitor Treatment Choice
Breast Cancer
Web Exclusives
CDK4/6 inhibitors have similar efficacy; therefore, clinicians should consider toxicity when selecting an optimal therapeutic approach. Read More ›
From The Editors June 2021
From The Editors June 2021
From the Editor
TON - June 2021 Vol 14, No 3
In the June issue of The Oncology Nurse-APN/PA (TON), we feature a selection of articles aimed at helping our readers stay informed on important issues relevant to nurses, navigators, and advanced practice providers as they care for patients with cancer. Read More ›
Nationwide Children’s Hospital: Meeting the Unique Needs of AYA Patients with Cancer
Cancer Center Profile
TON - June 2021 Vol 14, No 3
Nationwide Children’s Hospital in Columbus, OH, is one of the largest pediatric hospitals in the United States and is currently ranked as one of the top 10 children’s hospitals in the country by US News & World Report’s 2020-2021 “Best Children’s Hospitals Honor Roll” list. Read More ›

Page 80 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, TON print publication, and TON Bi-Weekly e‑newsletter.

Subscribe

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.